Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

被引：0

作者：

Pin-Nan Cheng

Lein-Ray Mo

Chun-Ting Chen

Chi-Yi Chen

Chung-Feng Huang

Hsing-Tao Kuo

Ching-Chu Lo

Kuo-Chih Tseng

Yi-Hsiang Huang

Chi-Ming Tai

Cheng-Yuan Peng

Ming-Jong Bair

Chien-Hung Chen

Ming-Lun Yeh

Chih-Lang Lin

Chun-Yen Lin

Pei-Lun Lee

Lee-Won Chong

Chao-Hung Hung

Te Sheng Chang

Jee-Fu Huang

Chi-Chieh Yang

Jui-Ting Hu

Chih-Wen Lin

Chia-Chi Wang

Wei-Wen Su

Tsai-Yuan Hsieh

Chih-Lin Lin

Wei-Lun Tsai

Tzong-Hsi Lee

Guei-Ying Chen

Szu-Jen Wang

Chun-Chao Chang

Sheng-Shun Yang

Wen-Chih Wu

Chia-Sheng Huang

Kwok-Hsiung Chou

Chien-Neng Kao

Pei-Chien Tsai

Chen-Hua Liu

Mei-Hsuan Lee

Chien-Yu Cheng

Ming-Chang Tsai

Chun-Jen Liu

Chia-Yen Dai

Han-Chieh Lin

Jia-Horng Kao

Wan-Long Chuang

Ming-Lung Yu

机构：

[1] National Cheng Kung University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[2] College of Medicine,Division of Gastroenterology

[3] National Cheng Kung University,Division of Gastroenterology, Department of Internal Medicine

[4] Tainan Municipal Hospital,Division of Gastroenterology, Department of Internal Medicine

[5] Tri-Service General Hospital Penghu Branch,Division of Gastroenterology and Hepatology, Department of Medicine

[6] National Defense Medical Center,Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center

[7] Tri-Service General Hospital,School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research

[8] National Defense Medical Center,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[9] Ditmanson Medical Foundation Chiayi Christian Hospital,Division of Gastroenterology, Department of Internal Medicine

[10] Kaohsiung Medical University Hospital,Department of Internal Medicine

[11] Kaohsiung Medical University,School of Medicine

[12] Kaohsiung Medical University,Division of Gastroenterology and Hepatology, Department of Medicine

[13] Chi Mei Medical Center,Institute of Clinical Medicine, School of Medicine

[14] St. Martin De Porres Hospital,Department of Internal Medicine

[15] Dalin Tzu Chi Hospital,School of Medicine, College of Medicine

[16] Buddhist Tzu Chi Medical Foundation,Center for Digestive Medicine, Department of Internal Medicine

[17] Tzuchi University,School of Medicine

[18] Taipei Veterans General Hospital,Division of Gastroenterology, Department of Internal Medicine

[19] National Yang Ming Chiao Tung University,Division of Hepato

[20] E-Da Hospital,Gastroenterology, Department of Internal Medicine

[21] I-Shou University,Department of Internal Medicine

[22] China Medical University Hospital,Department of Gastroenterology and Hepatology

[23] China Medical University,Department of Gastroenterology and Hepatology

[24] Taitung Mackay Memorial Hospital,Graduate Institute of Biomedical Science, College of Medicine

[25] Mackay Medical College,Liouying Division of Gastroenterology and Hepatology, Department of Internal Medicine

[26] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Division of Hepatology and Gastroenterology, Department of Internal Medicine

[27] Kaohsiung Municipal Siaogang Hospital,School of Medicine

[28] Kaohsiung Medical University Hospital,Division of Hepatogastroenterology, Department of Internal Medicine

[29] Kaohsiung Medical University,Department of Internal Medicine

[30] Keelung Chang Gung Memorial Hospital,Department of Gastroenterology, Division of Internal Medicine

[31] Chang Gung Memorial Hospital,Liver Center

[32] Chang Gung University,Division of Gastroenterology and Hepatology, E

[33] Chi Mei Medical Center,Da Dachang Hospital, and School of Medicine, College of Medicine

[34] Shin Kong Wu Ho-Su Memorial Hospital,Department of Gastroenterology and Hepatology

[35] Fu-Jen Catholic University,Department of Gastroenterology

[36] ChiaYi Chang Gung Memorial Hospital and College of Medicine,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[37] Chang Gung University,Division of Gastroenterology and Hepatology

[38] Kaohsiung Municipal Ta-Tung Hospital,Division of Gastroenterology, Department of Internal Medicine

[39] Kaohsiung Medical University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[40] Kaohsiung Medical University,Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine

[41] Show Chwan Memorial Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[42] Cathay General Hospital,Hepatitis Research Center and Department of Internal Medicine

[43] I-Shou University,Institute of Clinical Medicine, School of Medicine

[44] Taipei Tzu Chi Hospital,Institute of Public Health, School of Medicine

[45] Buddhist Tzu Chi Medical Foundation and School of Medicine,Department of Infectious Diseases

[46] Tzu Chi University,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[47] Changhua Christian Hospital,undefined

[48] Taipei City Hospital,undefined

[49] Kaohsiung Veterans General Hospital,undefined

[50] Far Eastern Memorial Hospital,undefined

来源：

Infectious Diseases and Therapy | 2022年 / 11卷

关键词：

Hepatitis C; Sofosbuvir; Velpatasvir; Direct-acting antivirals; Real-world; Taiwan;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：485 / 500

页数：15

共 50 条

[21] Effectiveness and safety of elbasvir grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
Jang, Eun Sun
Kim, Kyung-Ah
Kim, Young Seok
Kim, In Hee
Lee, Byung Seok
Lee, Youn Jae
Chung, Woo Jin
Jeong, Sook-Hyang
KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 : S1 - U328
[22] Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients with prior failure to DAA treatment
Graf, Christiana
Degasperi, Elisabetta
D'Ambrosio, Roberta
Llaneras, Jordi
Vermehren, Johannes
Dultz, Georg
Wetzstein, Nils
Herrmann, Eva
Zeuzem, Stefan
Buti, Maria
Lampertico, Pietro
Dietz, Julia
Sarrazin, Christoph
JOURNAL OF HEPATOLOGY, 2023, 78 : S98 - S99
[23] Effectiveness of Sofosbuvir / Velpatasvir in Treating Hepatitis C Virus Infection in RealWorld Setting
Janjua, Naveed
Wong, Stanley
Yu, Amanda
Butt, Zahid Ahmad
Rossi, Carmine
Alvarez, Maria
Binka, Mawuena
Darvishian, Maryam
Chapinal, Nuria
Cook, Darrel
Yoshida, Eric M.
Ramji, Alnoor
Tyndall, Mark
Krajden, Mel
HEPATOLOGY, 2018, 68 : 362A - 362A
[24] Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
Yu-Ting Huang
Yung-Yu Hsieh
Wei-Ming Chen
Shui-Yi Tung
Kuo-Liang Wei
Chen-Heng Shen
Kao-Chi Chang
Chung-Kuang Lu
Chih-Wei Yen
Sheng-Nan Lu
Chao-Hung Hung
Te-Sheng Chang
BMC Gastroenterology, 21
[25] Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
Huang, Yu-Ting
Hsieh, Yung-Yu
Chen, Wei-Ming
Tung, Shui-Yi
Wei, Kuo-Liang
Shen, Chen-Heng
Chang, Kao-Chi
Lu, Chung-Kuang
Yen, Chih-Wei
Lu, Sheng-Nan
Hung, Chao-Hung
Chang, Te-Sheng
BMC GASTROENTEROLOGY, 2021, 21 (01)
[26] The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real-world experience
El-Khayat, H. R.
Kamal, E. M.
El-Sayed, M. H.
El-Shabrawi, M.
Ayoub, H.
Rizk, A.
Maher, M.
El Sheemy, R. Y.
Fouad, Y. M.
Attia, D.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 838 - 844
[27] Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection
Takaoka, Yoshinari
Miura, Kouichi
Morimoto, Naoki
Ikegami, Tadashi
Kakizaki, Satoru
Sato, Ken
Ueno, Takashi
Naganuma, Atsushi
Kosone, Takashi
Arai, Hirotaka
Hatanaka, Takeshi
Tahara, Toshiyuki
Tano, Shigeo
Ohtake, Takaaki
Murohisa, Toshimitsu
Namikawa, Masashi
Asano, Takeharu
Kamoshida, Toshiro
Horiuchi, Katsuhiko
Nihei, Takeshi
Soeda, Atsuko
Kurata, Hidekazu
Fujieda, Takeshi
Ohtake, Toshiya
Fukaya, Yukimura
Iijima, Makoto
Watanabe, Shunji
Isoda, Norio
Yamamoto, Hironori
HEPATOLOGY RESEARCH, 2021, 51 (01) : 51 - 61
[28] Effectiveness of sofosbuvir and ledipasvir/sofosbuvir based regimens in hepatitis C virus genotype 3 infection: real-world data from Georgian hepatitis C elimination program
Tsertsvadze, T.
Chkhartishvili, N.
Abutidze, A.
Sharvadze, L.
Kerashvili, V.
Kamkamidze, G.
Zakalashvili, M.
Skaggs, B.
Gvinjilia, L.
Shadaker, S.
Nasrullah, M.
Gamkrelidze, A.
Kvaratskhelia, V.
Zeuzem, S.
Afdhal, N.
Arora, S.
Thornton, K.
Averhoff, F.
JOURNAL OF HEPATOLOGY, 2018, 68 : S281 - S282
[29] SOFOSBUVIR/VELPATASVIR EFFECTIVENESS IN TREATING CHRONIC HEPATITIS C GENOTYPE 3: A REAL-WORLD STUDY IN XINJIANG, CHINA
Sun, Wei
Aliturson, Maimaiti
HEPATOLOGY, 2024, 80 : S365 - S365
[30] Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China
Zhou, Yunjing
Liang, Minfeng
Li, Yiting
Chen, Xing
Yang, Jie
Bai, Honglian
Long, Yingzi
Zhang, Xiaohong
Lin, Chaoshuang
BMC GASTROENTEROLOGY, 2024, 24 (01)

← 1 2 3 4 5 →